DE60230988D1 - Proteine in der diabetes-proteomanalyse - Google Patents

Proteine in der diabetes-proteomanalyse

Info

Publication number
DE60230988D1
DE60230988D1 DE60230988T DE60230988T DE60230988D1 DE 60230988 D1 DE60230988 D1 DE 60230988D1 DE 60230988 T DE60230988 T DE 60230988T DE 60230988 T DE60230988 T DE 60230988T DE 60230988 D1 DE60230988 D1 DE 60230988D1
Authority
DE
Germany
Prior art keywords
diabetes
proteam
proteins
analysis
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60230988T
Other languages
English (en)
Inventor
Peter Mose Larsen
Stephen J Fey
Joern Nerup
Allan E Karlsen
Karin Nielsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pride Proteomics AS
Original Assignee
Pride Proteomics AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pride Proteomics AS filed Critical Pride Proteomics AS
Application granted granted Critical
Publication of DE60230988D1 publication Critical patent/DE60230988D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE60230988T 2001-05-29 2002-05-29 Proteine in der diabetes-proteomanalyse Expired - Lifetime DE60230988D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200100852 2001-05-29
PCT/DK2002/000369 WO2002097434A1 (en) 2001-05-29 2002-05-29 Proteins in diabetes proteome analysis

Publications (1)

Publication Number Publication Date
DE60230988D1 true DE60230988D1 (de) 2009-03-12

Family

ID=8160539

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60230988T Expired - Lifetime DE60230988D1 (de) 2001-05-29 2002-05-29 Proteine in der diabetes-proteomanalyse

Country Status (4)

Country Link
EP (2) EP1402257B1 (de)
AT (1) ATE421693T1 (de)
DE (1) DE60230988D1 (de)
WO (1) WO2002097434A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1490399A2 (de) * 2002-03-20 2004-12-29 Syddansk Universitet Humane, diabetesvermittelnde proteine
CA2513317A1 (en) * 2004-07-06 2006-01-06 Kuhnil Pharmaceutical Co., Ltd. Composition for the diagnosis of retinal vascular disease comprising aldolase and method for diagnosis using it
JP2007063225A (ja) 2005-09-01 2007-03-15 Takeda Chem Ind Ltd イミダゾピリジン化合物
EP2001875A2 (de) 2006-03-08 2008-12-17 Takeda San Diego, Inc. Glucokinase-aktivatoren
WO2007143434A2 (en) 2006-05-31 2007-12-13 Takeda San Diego, Inc. Indazole and isoindole derivatives as glucokinase activating agents
JP5419706B2 (ja) 2006-12-20 2014-02-19 タケダ カリフォルニア インコーポレイテッド グルコキナーゼアクチベーター
WO2008116107A2 (en) 2007-03-21 2008-09-25 Takeda San Diego, Inc. Piperazine derivatives as glucokinase activators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0934409A2 (de) * 1996-10-25 1999-08-11 Peter Mose Larsen Diabetes-vermittelnde proteine und therapeutische anwendungen derselben
US6753314B1 (en) * 1999-04-01 2004-06-22 Curagen Corporation Protein-protein complexes and methods of using same
CZ20013527A3 (cs) * 1999-04-02 2002-10-16 Corixa Corporation Sloučeniny a způsoby pro terapii a diagnostiku karcinomu plic
EP1185862A2 (de) * 1999-06-01 2002-03-13 Proteome Sciences Plc Verfahren und zusammensetzungen bezüglich insulinresistenz-erkrankungen
GB9914890D0 (en) * 1999-06-25 1999-08-25 Univ Buckingham Methods and compositions relating to pancreatic islet and -cell dysfunction

Also Published As

Publication number Publication date
ATE421693T1 (de) 2009-02-15
EP1402257B1 (de) 2009-01-21
EP2161578A1 (de) 2010-03-10
WO2002097434A1 (en) 2002-12-05
EP1402257A1 (de) 2004-03-31

Similar Documents

Publication Publication Date Title
DK221090A (da) Fremgangsmaade og apparat til diagnostisk analyse ved stroemmaaling
DK0943097T3 (da) Fremgangsmåde til at påvise IgE
TWI256975B (en) Compositions containing a urea derivative dye for detecting an analyte and methods for using the same
DE60041839D1 (de) Auto-Antikörper gegen Annexin-Proteine als Marker für Lungenkrebs
DK1155325T3 (da) Fremgangsmåde til diagnosticering af og skelnen mellem typer af slagtilfælde
DE60025526D1 (de) Elisa für vegf
WO2004063704A3 (en) Vitamin d assay
CY1107490T1 (el) Μεθοδος για την ταυτοποιηση δειγματος σε θηλαστικα καθως και κιτ για την εκτελεση αυτης της μεθοδου
EP1780537A4 (de) Proteomanalyseverfahren für phosphoryliertes protein
ATE496294T1 (de) Analyseset mit stechhilfe und messgerät
MXPA04007285A (es) Dispositivo para el analisis automatico de una muestra liquida.
DE60230988D1 (de) Proteine in der diabetes-proteomanalyse
SE8802944L (sv) Material foer lapptestning
NO20050130L (no) Bakteriell testmetode ved glykatert merket binding
DE59911255D1 (de) ELISPOT-Verfahren zur Quantifizierung der Aktivität von menschlichen und tierischen Zellen, zur insbesondere Blutzellen
GR1004071B (el) Συγχρονη αναλυση δειγματων αιματος και εκτιμηση περιεχομενου αιματος (αιμοσφαιρινη).
DE60035267D1 (de) Verfahren zur analyse der menge an intraabdominalem fettgewebe
DE59710505D1 (de) Verwendung von tiefgefrorenem Blut für biologische Untersuchungsverfahren
DE69523492D1 (de) Immunoassay-Reagenzien, Testsätze und Verfahren
BRPI0515346A (pt) associação de polimorfismos protéicos com doenças coronárias do coração
AU6366798A (en) Cyanide-containing hemoglobin reagent composition and method providing acceptable precision, accuracy and freedom from white cell interference on automated hematology analyzers
DE60326269D1 (de) Verfahren zur detektion von prpsc unter verwendung von gruppe ii aminoglykosid antibiotika
ATE278965T1 (de) Knorpelresorptionsassays
DK1297342T3 (da) Metode til diagnostisk bestemmelse af Alzheimer's sygdom på basis af holo-transcobalamin II
GR1003227B (el) Ποσοτικη μετρηση ενζυματικης δραστηριοτητας

Legal Events

Date Code Title Description
8364 No opposition during term of opposition